EP2258364A4 - PREVENTIVE AND / OR REMEDY AGENT FOR VASCULAR DISEASES - Google Patents

PREVENTIVE AND / OR REMEDY AGENT FOR VASCULAR DISEASES

Info

Publication number
EP2258364A4
EP2258364A4 EP09728612A EP09728612A EP2258364A4 EP 2258364 A4 EP2258364 A4 EP 2258364A4 EP 09728612 A EP09728612 A EP 09728612A EP 09728612 A EP09728612 A EP 09728612A EP 2258364 A4 EP2258364 A4 EP 2258364A4
Authority
EP
European Patent Office
Prior art keywords
remedy
preventive
vascular diseases
vascular
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09728612A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2258364A1 (en
Inventor
Tomihisa Kawasaki
Toshiyuki Funatsu
Sakata Chinatsu Sakurai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of EP2258364A1 publication Critical patent/EP2258364A1/en
Publication of EP2258364A4 publication Critical patent/EP2258364A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP09728612A 2008-04-01 2009-03-31 PREVENTIVE AND / OR REMEDY AGENT FOR VASCULAR DISEASES Withdrawn EP2258364A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008095370 2008-04-01
PCT/JP2009/056708 WO2009123210A1 (ja) 2008-04-01 2009-03-31 血管性疾患の予防剤及び／又は治療剤

Publications (2)

Publication Number Publication Date
EP2258364A1 EP2258364A1 (en) 2010-12-08
EP2258364A4 true EP2258364A4 (en) 2012-07-25

Family

ID=41135578

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09728612A Withdrawn EP2258364A4 (en) 2008-04-01 2009-03-31 PREVENTIVE AND / OR REMEDY AGENT FOR VASCULAR DISEASES

Country Status (13)

Country Link
US (1) US20110034504A1 (zh)
EP (1) EP2258364A4 (zh)
JP (1) JP5589838B2 (zh)
KR (1) KR20100137448A (zh)
CN (1) CN101983056A (zh)
AU (1) AU2009232710A1 (zh)
BR (1) BRPI0908584A2 (zh)
CA (1) CA2720278A1 (zh)
IL (1) IL208231A0 (zh)
MX (1) MX2010010869A (zh)
RU (1) RU2010144554A (zh)
WO (1) WO2009123210A1 (zh)
ZA (1) ZA201006660B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012170839A2 (en) * 2011-06-09 2012-12-13 Cardeus Pharmaceuticals, Inc. Treatment of neuroinflammatory disease with selective cox1 inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
AUPR878201A0 (en) * 2001-11-09 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. New compounds
CN101237868A (zh) * 2005-06-13 2008-08-06 伊兰制药国际有限公司 纳米粒氯吡格雷和阿司匹林组合制剂
CA2621800A1 (en) * 2005-09-06 2007-03-15 Astellas Pharma Inc. Fine particles of poorly soluble drug having enteric base material adsorbed on the surface thereof
WO2007091719A1 (ja) * 2006-02-07 2007-08-16 Mochida Pharmaceutical Co., Ltd. 抗gpvi抗体の併用療法及び新規医薬用途
JPWO2008029912A1 (ja) * 2006-09-07 2010-01-21 国立大学法人 岡山大学 シクロオキシゲナーゼ１（ｃｏｘ−１）選択的阻害活性を有するベンズアミドを骨格とする化合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DAYKIN H J ET AL: "Arterial antithrombotic effects of aspirin, heparin, enoxaparin and clopidogrel alone, or in combination, in the rat", THROMBOSIS RESEARCH, TARRYTOWN, NY, US, vol. 118, no. 6, 1 January 2006 (2006-01-01), pages 755 - 762, XP027962690, ISSN: 0049-3848, [retrieved on 20060101] *

Also Published As

Publication number Publication date
MX2010010869A (es) 2010-11-12
WO2009123210A1 (ja) 2009-10-08
JPWO2009123210A1 (ja) 2011-07-28
ZA201006660B (en) 2011-12-28
US20110034504A1 (en) 2011-02-10
KR20100137448A (ko) 2010-12-30
CN101983056A (zh) 2011-03-02
CA2720278A1 (en) 2009-10-08
AU2009232710A1 (en) 2009-10-08
RU2010144554A (ru) 2012-05-10
BRPI0908584A2 (pt) 2015-09-15
JP5589838B2 (ja) 2014-09-17
IL208231A0 (en) 2010-12-30
EP2258364A1 (en) 2010-12-08

Similar Documents

Publication Publication Date Title
EP2361089A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE
EP2432476A4 (en) METHOD FOR THE TREATMENT OR PREVENTION OF EYE DISEASES
EP2118074A4 (en) COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIAC DISEASES
EP2440209A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HEART FAILURE
EP2125855A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER OR OTHER DISEASES
GB0802634D0 (en) Catheter
EP2497482A4 (en) COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF INFLUENZA AVIRUSED INDUCED DISEASES
EP2313146A4 (en) DEVICES FOR TREATING VASCULAR ANEVRYSM
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
HK1162366A1 (zh) 用於治療和/或預防疾病的裝置和方法
IL209216A (en) Preparations for the prevention and treatment of neurodegenerative diseases
HK1159498A1 (zh) 用於治療癌症的方法和組合物
EP2371415A4 (en) CATHETER
HK1168830A1 (zh) 薄棉紙分配器及製造該分配器的方法
EP2341936A4 (en) METHOD FOR TREATING OR PREVENTING IL-1ß-CONTAINED ILLNESSES
EP2340027A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
PL2254589T3 (pl) Związki i sposoby zapobiegania lub leczenia restenozy
IL206941A0 (en) Catheter
ZA201007362B (en) Conjugates for the treatment of mesothelioma
PL2234631T3 (pl) Związki i metody stosowane w terapii choroby naczyniowej
HUP0800419A2 (en) Catheter
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
EP2258364A4 (en) PREVENTIVE AND / OR REMEDY AGENT FOR VASCULAR DISEASES
HK1185345A1 (zh) 用於預防和治療心血管疾病的化合物
GB0812940D0 (en) Medical implant

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100922

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SAKURAI (SAKATA), CHINATSU

Inventor name: FUNATSU, TOSHIYUKI

Inventor name: KAWASAKI, TOMIHISA

RAX Requested extension states of the european patent have changed

Extension state: RS

Payment date: 20100922

A4 Supplementary search report drawn up and despatched

Effective date: 20120627

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 9/10 20060101ALI20120621BHEP

Ipc: A61K 31/4365 20060101AFI20120621BHEP

Ipc: A61P 9/00 20060101ALI20120621BHEP

Ipc: A61P 9/08 20060101ALI20120621BHEP

Ipc: A61P 43/00 20060101ALI20120621BHEP

Ipc: A61K 45/06 20060101ALI20120621BHEP

Ipc: A61P 7/02 20060101ALI20120621BHEP

Ipc: A61K 31/4196 20060101ALI20120621BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130129